41 results about "Acid Jelly" patented technology

The invention is directed to a method of treating a wound (e.g., to suppress scar formation) in an individual in need thereof comprising contacting the wound with an effective amount of a composition comprising (i) Wharton's jelly stem cells (WJSCs), (ii) a cell culture medium that has been conditioned with WJSCs, (iii) a lysate of WJSCs, (iv) a cell culture medium that has been conditioned with WJSCs exposed to apoptotic skin cells and keloid cells, or (v) a combination thereof. The invention is directed to a medical dressing (e.g., pharmaceutical compositions) comprising Wharton's jelly stem cells (WJSCs), a cell culture medium that has been conditioned with WJSCs, a lysate of WJSCs, a cell culture medium that has been conditioned with WJSCs exposed to apoptotic skin cells and keloid cells, or a combination thereof.

The invention relates to a microcrystalline cellulose-chitosan fiber, which is characterized in that the components contained in the stock solution and the mass ratio ranges of each component are as follows: chitosan 2wt%-5wt%, glycerin 0.1wt%-1.0wt %, zinc acetate 1wt%-5wt%, microcrystalline cellulose 1wt%-10wt%, and water. It is prepared by wet and dry method. Because of the addition of microcrystalline cellulose, the charged state of chitosan molecules is improved, the viscosity of chitosan acidic solution is reduced, and the generation of jelly is prevented, which replaces the traditional method of adding urea, isopropanol, dichloroacetic acid, etc. The raw materials produced by the jelly, as well as reagents such as acetic acid that act as viscosifiers and defoamers, save raw materials and reduce costs.

The invention discloses a synergistic agent and a preparation method thereof, wherein the synergistic agent comprises the following raw materials according to proportion by weight: 70.8-87.5 parts of stone potassium, 3-8 parts of polyaspartic acid, 3-8 parts of maleic anhydride, 0.3-0.5 parts of azone, 5-10 parts of urea or ammonium hydrogen carbonate, 0.4-0.7 parts of d bacteria liquid, 0.3-0.8 parts of EDTA (Ethylene Diamine Tetraacetic Acid) and 0.2-0.5 parts of n-butyl alcohol. The preparation method of the stone potassium comprises the following steps: respectively crashing 50 parts of zeolite ore, 20 parts of phosphorite and 30 parts of leopoldite into 100-200 meshes and then uniformly mixing so as to obtain a mixture; taking 73.5-87.3 parts of mixture, 2-4 parts of urea, 2-5 parts of phosphorus pentoxide, 1-2 parts of potassium sulfate, 0.2-0.5 parts of ammonium molybdate or sodium molybdate, 1-2 parts of manganous sulfate, 3-6 parts of ferrous sulfate, 1-2 parts of zinc sulfate, 1-2 parts of sodium borate, 0.5-1 parts of copper sulfate and 1-2 parts of fulvic acid; and stirring and sealing up for keeping standby. The preparation method of the bacteria liquid comprises the following steps: uniformly mixing colon bacillus, Fusarium moniliforme, Corynebacterium pekinense, Streptomyces jingyangensis, Bacillus megatherium, Bacillus mucilaginosus and Streptomyces according to a proportion of 0.5%: 0.5%: 0.5%: 0.5%: 0.5%: 0.5%: 0.5%. The synergistic agent is multipurpose, nutritious, low in cost, non-toxic, nuisanceless and free of residue.

The invention relates to an external plaster for treating bone injuries. The raw materials of the external plaster involve the following Chinese medicinal materials by weight: 100-200g of poplar buds, 150-250g of elm barks, 50-150g of calcined oxhorns, 50-100g of cartialgenous, 100g of Achyranthes, 100g of monkshood, 100g of Radix Aconiti kusnezoffii, 150g of radix clematidis, 100-150g of pseudo-ginseng, 100g of the roots of fangji and 150g of rhizoma corydalis. The preparation method of the external plaster comprises the steps of: crushing the medicinal materials into fine powder, sieving the powder with an 80-mesh sieve and mixing the powder uniformly, then putting the powder into a pot, adding 2000ml of boiled water at 80DEG C, stirring them evenly and soaking them for 30min, decocting the mixture with slow fire and adding 500ml of edible vinegar simultaneously, and carrying out decoction for 60min till obtaining a black jelly pasty ointment for stand-by use. Compared with the prior art, the plaster provided by the invention is good for patients with bone injuries, the treatment period is shortened and the cure rate is high, so that the plaster can substitute the therapies of western medicine surgeries and operations employing steel nails and iron hooks. Besides, the plaster does not cause sequela, or require amputation, and can prevent infection. According to years of clinical practice, and diagnosis and observation of tens of thousands of patients, the plaster has a total effective rate of 97.76% and a cure rate of 93% on bone fractures, and a total effective rate of 93% and a cure rate of 81% for treatment of lumbar disc herniation.

An aloe pineapple jelly and a manufacturing method for the aloe pineapple jelly relate to a health food and the manufacturing method for the food. The invention relates to a health food with the advantages of good taste and convenient eating, which can carry through industrial production. The manufacturing method is: the preparation of a colla corii asini wine solution is as following: heating the follow components according to the weight portion of 10 to 20 portions of colla corii asini, 20 to 30 of yellow wine, 40 to 60 portions of white granulated sugar, and 20 to 40 portions of honey to 60 to 80 DEG C and then preserving heat and mixing for 2 hours. The aloe and the pineapple are beaten into slurry according to the weight portion of 10 to 20 portions of the aloe and 40 to 60 portions of the pineapple; the preparation of the aloe pineapple jelly: cooling the colla corii asini wine solution to 20 to 25 DEG C and adding the aloe pineapple slurry into the colla corii asini wine solution gradually and cooling to the normal temperature and pouring the cooled solution into a die to form a gel shape. The invention comprises the colla corii asini, the aloe and the pineapple and has the supply function of the colla corii asini, and also comprises various vitamins and minerals. The invention has sweet and sour flavor with the fragrance of wine and is a health food with high quality.

The invention discloses a preparation method of high-temperature-resistant and easy-to-chew low-glycemic index (GI) konjak gel particles. The preparation method comprises the following steps: mixing and granulating: uniformly mixing konjak powder, sodium alginate, sodium carbonate and water, then standing for 0.5-2h to obtain paste jelly, and freezing the paste jelly into particles at the temperature of 5 DEG C or below; forming: soaking the prepared particles in a calcium ion-containing solution, soaking the particles in a calcified solution at the temperature of 80-95 DEG C for 15-40 min, and fishing out the gel particles from the calcified solution; and adding the fished-out particles into an erythritol preserving fluid, and performing packaging after sterilizing at 115-121 DEG C for 10-30 min. The mass ratio of the konjak powder to the sodium alginate to the sodium carbonate to the water is (6-12): (3-6): (0.6-1.2): (150-300). The calcium ion-containing solution includes calcium chloride or calcium lactate; the concentration of the calcium ion-containing solution is 0.05-0.15 mol / l; and the mass ratio of the calcium ion-containing solution to raw material particles is 1: (1-3).The gel particles have the characteristic of high temperature resistance of the konjak vegetarian diet, and are still easy to chew under the condition that the content of konjak glucomannan is extremely high.

The invention belongs to the field of medical biocomposite materials, and specifically discloses a preparation method and application of a cryogel scaffold. The preparation method of the cryogel support comprises the following steps of double bond modified sericin preparation: sericin powder is dry dissolved in phosphate buffer solution, methacrylic anhydride is added dropwise, and impurities are removed; sericin cryogel preparation: double bond The modified sericin solution is mixed with ammonium persulfate solution and tetramethylethylenediamine solution, and then frozen; preparation of the sericin jelly gel scaffold: the sericin jelly gel is reacted in silver nitrate solution, and freeze-dried. Application of sericin / silver composite cryogel scaffold as a hemostatic material. The invention provides a relatively new preparation method of sericin jelly gel bracket, which is simpler and more environmentally friendly; it realizes the preparation of sericin jelly gel as a raw material; The activity is better.